High puritySemaglutide Raw Material Powder Advanced Pharmaceuticals

Sales manager:  Emily
Whatsapp:  +85270264551
Email:  Zhulihua@haber-industrial.com

Company Profile Haibo Industrial Co., Ltd. was established in 2024 with strong research and development capabilities and superb synthesis technology, as well as advanced quality control measures. Effectively promote the joint venture and cooperation with the major enterprises, manufacturers, with the idea of industrial development to serve the society and the majority of users. We always adhere to the market demand as the orientation, constantly synthesizing new high-tech chemical products and medical intermediates, mainly exported to the United States, Europe, India, South Africa, Nigeria and other countries and regions, has a wealth of export experience, to ensure transportation safety, can let each customer as soon as possible to safely receive the goods.

• Indications

  1. Treatment of type 2 diabetes: It is used for blood sugar control in adult patients with type 2 diabetes on the basis of diet control and exercise. Especially for those patients whose blood sugar is still poorly controlled after treatment with metformin and/or sulfonylurea drugs. Semaglutide can stimulate insulin secretion, and this stimulation is glucose concentration-dependent, that is, it enhances insulin secretion when blood sugar rises, effectively reduces high blood sugar levels, and reduces the risk of hypoglycemia when blood sugar is normal; at the same time, it inhibits glucagon secretion, reduces liver glucose output, and can also delay gastric emptying, prolong nutrient absorption time, and further stabilize blood sugar levels.

  2. Reduction of cardiovascular disease risk: It is suitable for adult patients with type 2 diabetes and cardiovascular disease, and can reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction or non-fatal stroke). It may protect the cardiovascular system by improving endothelial function, reducing inflammatory response and directly protecting the heart.

  3. Weight management: It can be used to assist weight management for adults with BMI ≥ 30kg/m² (obesity) or BMI ≥ 27kg/m² (overweight) and at least one weight-related complication (such as hypertension, dyslipidemia, cardiovascular disease, sleep apnea, etc.). Semaglutide acts on the appetite regulation center of the hypothalamus, increases satiety signals, and affects the reward circuit of the limbic system, reducing the desire for high-fat and high-sugar foods, thereby reducing food intake and achieving weight loss.

• 
•